Stonepine Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Buy |
|
|||||
|
2025
Q1 | $3.26M | Buy |
|
|||||
|
2024
Q4 | $1.91M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $8.54M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $7.8M | Buy |
|
|||||
|
2019
Q2 | $5.53M | Buy |
|
|||||
|
2019
Q1 | $5.81M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $12.8M | Sell |
|
|||||
|
2017
Q3 | $18.3M | Sell |
|
|||||
|
2017
Q2 | $17.7M | Buy |
|
|||||
|
2017
Q1 | $5.7M | Sell |
|
|||||
|
2016
Q4 | $7.77M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2.35M | Buy |
|